Antioxidant strategy for cardiovascular diseases

Lancet. 2001 May 26;357(9269):1705-6. doi: 10.1016/s0140-6736(00)04876-5.
No abstract available

Publication types

  • Comment
  • Comparative Study
  • Letter
  • Meta-Analysis

MeSH terms

  • Aspirin / administration & dosage*
  • Aspirin / adverse effects
  • Cardiovascular Diseases / mortality
  • Cardiovascular Diseases / prevention & control*
  • Dose-Response Relationship, Drug
  • Humans
  • Randomized Controlled Trials as Topic
  • Survival Analysis
  • Treatment Outcome
  • Vitamin E / administration & dosage*
  • Vitamin E / adverse effects

Substances

  • Vitamin E
  • Aspirin